OBJECTIVE -To evaluate the association between cognitive dysfunction and other barriers and glycemic control in older adults with diabetes.RESEARCH DESIGN AND METHODS -Patients over the age of 70 years presenting to a geriatric diabetes clinic were evaluated for barriers to successful diabetes management. Patients were screened for cognitive dysfunction with the Mini Mental State Examination (MMSE) and a clock-drawing test (CDT) scored by 1) a method validated by Mendez et al. and 2) a modified CDT (clock in a box [CIB]). Depression was evaluated with the Geriatric Depression Scale. Interview questionnaires surveyed activities of daily living (ADLs) and instrumental ADLs (IADLs), as well as other functional disabilities.RESULTS -Sixty patients (age 79 Ϯ 5 years, diabetes duration 14 Ϯ 13 years) were evaluated. Thirty-four percent of patients had low CIB (Յ5), and 38% of patients had low CDT (Յ13). Both CIB as well as CDT were inversely correlated with HbA 1c , suggesting that cognitive dysfunction is associated with poor glycemic control (r ϭ Ϫ0.37, P Ͻ 0.004 and r ϭ Ϫ0.38, P Ͻ 0.004, respectively). Thirty-three percent of patients had depressive symptoms with greater difficulty completing the tasks of the IADL survey (5.7 Ϯ 1.7 vs. 4.6 Ϯ 2.0; P Ͻ 0.03). These older adults with diabetes had a high incidence of functional disabilities, including hearing impairment (48%), vision impairment (53%), history of recent falls (33%), fear of falls (44%), and difficulty performing IADLs (39%).CONCLUSIONS -Older adults with diabetes have a high risk of undiagnosed cognitive dysfunction, depression, and functional disabilities. Cognitive dysfunction in this population is associated with poor diabetes control.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.